LFF269

DRUG2 trials

Sponsors

Novartis Pharmaceuticals

Conditions

HypertensionPart 1 - Healthy VolunteersPart 2 - Patients With Hypertension

Phase 1

To Evaluate Pharmacokinetics of LFF269 in Healthy Volunteers and Patients With Hypertension

TerminatedNCT02047656

Novartis PharmaceuticalsPart 1 - Healthy Volunteers, Part 2 - Patients With Hypertension

Start: 2013-08-31End: 2014-08-31Updated: 2016-04-01

Phase 2

LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension

TerminatedNCT01373086

Novartis PharmaceuticalsHypertension

Start: 2011-05-31End: 2011-10-31Updated: 2020-12-17